US Stock MarketDetailed Quotes

AVTX Avalo Therapeutics

Watchlist

8.8100
-0.2800-3.08%

Close Dec 24 13:00 ET

92.18MMarket Cap0.09P/E (TTM)

Avalo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Avalo Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	249.000K / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q3249.000K / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Avalo Therapeutics Earnings Reports

Avalo Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 7 07:08 ET

Avalo Therapeutics | 8-K: Avalo Reports Third Quarter 2024 Financial Results and Recent Business Updates

Nov 7 07:03 ET

Avalo Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 12 07:05 ET

Avalo Therapeutics | 8-K: Avalo Reports Second Quarter 2024 Financial Results and Provides Business Updates

Aug 12 07:05 ET

Analyst Rating

Updated: Dec 20, 2024

Strong Buy

Buy
75.00%
Hold
25.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall